Dual specificity phosphatase 6 as a new therapeutic target candidate for epithelial ovarian cancer

被引：1
|
作者：
Sato, Seiya [1 ]
Itamochi, Hiroaki [2 ]
机构：
[1] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane, Japan
[2] Iwate Med Univ, Sch Med, Dept Clin Oncol, Yahaba, Iwate, Japan
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
ONCOGENE ADDICTION; BEVACIZUMAB; INHIBITION; DUSP6;
D O I：
10.21037/atm.2019.12.105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
    Alexandrova, Elena
    Pecoraro, Giovanni
    Sellitto, Assunta
    Melone, Viola
    Ferravante, Carlo
    Rocco, Teresa
    Guacci, Anna
    Giurato, Giorgio
    Nassa, Giovanni
    Rizzo, Francesca
    Weisz, Alessandro
    Tarallo, Roberta
    [J]. CANCERS, 2020, 12 (06) : 1 - 32
  • [2] PAD ENZYMES AS A CANDIDATE THERAPEUTIC TARGET IN OVARIAN CANCER
    O'Toole, S.
    Melarcode, H.
    Elbaruni, S.
    AbuSaadeh, F.
    Ward, M.
    Gallagher, M.
    Norris, L.
    Gray, S.
    O'Leary, J.
    Mohamed, B.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A496 - A497
  • [3] Inhibition of dual specificity phosphatase 6 (DUSP6) sensitizes ovarian cancer cells to chemotherapeutic agents
    Beffa, L. B.
    James, N.
    Oliver, M.
    Freiman, R.
    DiSilvestro, P. A.
    Ribeiro, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 43 - 43
  • [4] β-catenin as a TIC therapeutic target in epithelial ovarian cancer.
    Nagaraj, Anil Belur
    Joseph, Peronne
    Kovalenko, Olga
    Singh, Sareena
    Armstrong, Amy
    DiFeo, Analisa
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [5] IDENTIFICATION OF A NOVEL CANDIDATE BIOMARKER FOR DIAGNOSIS AND THERAPEUTIC OVARIAN CANCER TARGET
    Park, Kyoungsook
    Son, Chaeyeon
    Song, Sang Yong
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 108 - 108
  • [6] Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer
    Lee, Jung Uee
    Huang, Songmei
    Lee, Min Hee
    Lee, Seong Eun
    Ryu, Min Jeong
    Kim, Soung Jung
    Kim, Yong Kyung
    Kim, Seul Young
    Joung, Kyong Hye
    Kim, Jin Man
    Shong, Minho
    Jo, Young Suk
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (01) : 93 - 101
  • [7] Clinical significance of cadherin-6 expression in primary and recurrent epithelial ovarian cancer and its association with outcomes: A potential therapeutic target for epithelial ovarian cancer
    Shintani, Daisuke
    Hanaoka, Mieko
    Sato, Sho
    Yano, Mitutake
    Ogasawara, Aiko
    Kato, Tomomi
    Yabuno, Akira
    Yasuda, Masanori
    Kaneda, Yuki
    Nagata, Motoko
    Hasegawa, Kosei
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S116 - S116
  • [8] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Danhua Ruan
    Jirui Wen
    Fei Fang
    Yuqin Lei
    Zhiwei Zhao
    Yali Miao
    [J]. Cell Death Discovery, 9
  • [9] Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
    Lee, Jeong-Won
    Ryu, Ji-Yoon
    Yoon, Gun
    Jeon, Hye-Kyung
    Cho, Young-Jae
    Choi, Jung-Joo
    Song, Sang Yong
    Do, In-Gu
    Lee, Yoo-Young
    Kim, Tae-Joong
    Choi, Chel Hun
    Kim, Byoung-Gie
    Bae, Duk-Soo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 221 - 229
  • [10] CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
    Feng, Xiaojie
    Bai, Xupeng
    Ni, Jie
    Wasinger, Valerie C.
    Beretov, Julia
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
12345